Hemangioma activity score evaluation in infantile hemangioma patients: a retrospective study

作者
Putri Halla Shavira,M. Yulianto Listiawan,Sawitri Sawitri,Cita Rosita Sigit Prakoeswa,Rahmadewi,Linda Astari,Budi Utomo,Ni Putu Susari Widianingsih
出处
期刊:Bali Medical Journal [DiscoverSys]
卷期号:13 (1): 913-917
标识
DOI:10.15562/bmj.v13i1.5284
摘要

Introduction: Infantile hemangioma (IH) is a benign vascular tumor commonly found in children. Generally, no special therapy is required because spontaneous resolutions occur. However, in some cases, therapy is required due to the potential of complications. During therapy, the side effects and effectiveness of therapy must be evaluated. One of the assessment tools is the Hemangioma Activity Score (HAS). HAS is a simple and objective assessment to evaluate the successful treatment of IH by observing swelling, color, and ulceration. The use of HAS in Indonesia is still minimal. This study aims to evaluate HAS before and after therapy in IH patients at Dr. Soetomo General Academic Hospital and Surabaya Skin Centre. Methods: Twenty-seven patient medical records were selected based on the inclusion and exclusion criteria. This study is an analytic cross-sectional retrospective using consecutive sampling. The collected data were tested for suitability using Cohen's Kappa. Pre- and post-tests were carried out using the Shapiro-Wilk and Wilcoxon tests afterward. Results: Among 27 IH cases occurred in females (81.4%), with the youngest age of the patient being 1 month and the oldest being 8 years. The onset of lesions in all patients appeared before 1 year of age. The most frequent location for IH lesions was the facial area (51.8%), with a clinical manifestation being plaque (37%). The most common therapy used in this study was pulse dye laser (PDL) (48.1%). Analysis of the difference in HAS before and after therapy showed p value = 0.00, a statistically significant difference in HAS before and after therapy. Conclusions: The hemangioma activity score is an effective measurement tool for measuring the severity of IH and evaluating the effectiveness of therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
阿瞒发布了新的文献求助10
刚刚
菁菁完成签到,获得积分20
刚刚
1秒前
柯科研发布了新的文献求助10
1秒前
科目三的应助被羞涩的渊思采纳,获得10
1秒前
小卤蛋发布了新的文献求助10
2秒前
yy发布了新的文献求助10
2秒前
兰金发布了新的文献求助20
3秒前
kkkk完成签到,获得积分10
3秒前
慕青的应助被云定长空采纳,获得10
3秒前
迷路的夏山完成签到 ,获得积分10
3秒前
3秒前
4秒前
闪闪的YOSH完成签到,获得积分10
4秒前
CATH完成签到 ,获得积分10
4秒前
在水一方的应助被神秘墨镜男采纳,获得80
4秒前
lhy发布了新的文献求助100
5秒前
兰战非完成签到 ,获得积分10
5秒前
岳博完成签到,获得积分10
5秒前
35发布了新的文献求助10
5秒前
5秒前
怕黑的缘分的应助被WYL采纳,获得10
6秒前
慕青的应助被hhh采纳,获得10
6秒前
Liangyu完成签到,获得积分10
6秒前
6秒前
lethe完成签到,获得积分10
6秒前
科研通AI2S的应助被18781913856采纳,获得10
6秒前
李健的应助被小乌孙采纳,获得50
6秒前
乐乐的应助被强健的碧琴采纳,获得10
6秒前
7秒前
问未发布了新的文献求助10
7秒前
王者发布了新的文献求助10
7秒前
Maggie完成签到,获得积分10
7秒前
7秒前
天天快乐的应助被董浩楠采纳,获得10
7秒前
7秒前
星耀完成签到,获得积分10
7秒前
终梦的应助被无事小神仙采纳,获得20
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346